Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
62M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
-1.66M
-
Total reported value, excl. options
-
$789M
-
Value change
-
-$34M
-
Number of buys
-
55
-
Number of sells
-
-54
-
Price
-
$21.44
Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q3 2018
140 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q3 2018.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 62M outstanding shares and own 59.37% of the company stock.
Largest 10 shareholders include OppenheimerFunds, Inc. (4.09M shares), BlackRock Inc. (3.23M shares), BB BIOTECH AG (2.99M shares), FMR LLC (2.62M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.28M shares), Vanguard Group Inc (2.27M shares), EcoR1 Capital, LLC (1.48M shares), STATE STREET CORP (1.24M shares), Point72 Asset Management, L.P. (1.13M shares), and INTERWEST VENTURE MANAGEMENT CO (1.07M shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.